Cosmos Health Q3 revenue rises as gross margin improves

Cosmos Health

17/11/2025 14:28

Overview

Cosmos Health Q3 2025 revenue rises 38% yr/yr to a record $17.11 mln

Adjusted EBITDA loss improves 74% yr/yr, reflecting stronger gross profitability

Company secures $300 mln digital financing facility, enhancing financial flexibility

Outlook

Company did not provide specific financial guidance for future quarters in press release

Result Drivers

CORE SEGMENTS - Record-breaking performance across all core business segments, including Cana Laboratories and Decahedron in the UK, drove results

GLOBAL EXPANSION - Expansion of proprietary brands like Sky Premium Life and C-Sept/C-Scrub contributed to growth

GROSS MARGIN IMPROVEMENT - Gross margin expanded due to improved efficiencies and a stronger sales mix

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
$17.1 mln
Q3 Gross Profit
$2.60 mln


Press Release: ID:nGNEdHBkg

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)